Xortx Therapeutics Inc. Stock
Xortx Therapeutics Inc. took a tumble today and lost -€0.210 (-8.710%).
Our community identified positive and negative aspects for Xortx Therapeutics Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Xortx Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Xortx Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
News
XORTX Reprices Warrants Issued in Connection with Previous Private Placements
CALGARY, AB - April 30, 2024 - XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on
XORTX Announces Publication of Key Research in ADPKD
CALGARY, AB – April 22, 2024 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company
XORTX Welcomes New Member to the Board of Directors
CALGARY, AB – April 8, 2024 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company